Skip to content
★ Sign in to follow
MR

Melanie Ross

Surgical Innovations Group plc
Total declarations
6
Company
1
▲ Purchases (3 ops.)
€107k
▼ Sales (3 ops.)
€87k

Latest filing published 15 Mar 2019 for Surgical Innovations Group plc, €20k.

Filing timeline

BuySale
Melanie Ross

Insider track record

Disclosed buys
3
Disclosed sells
3
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Melanie Ross: trading record in brief

Melanie Ross discloses dealings in Surgical Innovations Group plc to RNS (LSE). In total, 6 filings cover trades dated from 31 March 2017 to 15 March 2019.

On the open market, the record shows 3 purchases worth €107k and 3 sales worth €87k. Taken together, the purchases exceed the sales by €21k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2019: 1 purchase and 1 sale on the market.

The median purchase comes to €25k.

The record was last updated on 15 March 2019 with an open-market sale (€20k) in Surgical Innovations Group plc. The latest purchase dates back some time: it was published 2,796 days ago, on 15 March 2019. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to Melanie Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▼
    Chief Financial Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    17,158 GBP20FCA-NSM
    504,644 shares@ £0.03410.4% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20190315162718_14004663_20200326185133845_14375-0
  • ▲
    Chief Financial Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    17,183 GBP0FCA-NSM
    504,644 shares@ £0.034110.4% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20190315162718_14004663_20200326185133845_14375-1
    Canonical exit: 13 Jun 2019 (T+90)
  • ▼
    Chief Operating Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    36,300 GBP30FCA-NSM
    967,996 shares@ £0.037540.1% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20180323152505_13579929_20200330111426972_6197-0
  • ▲
    Chief Operating Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    54,316 GBP29FCA-NSM
    1,472,640 shares@ £0.035759.9% of flow1. & 2. - London Stock Exchange, AIM 3. - Off marketISIN GB0004016704FCA-NSM:LSE20180323152505_13579929_20200330111426972_6197-1
    Canonical exit: 20 Jun 2018 (T+90)
  • ▼
    Chief Operating Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    21,503 GBP13FCA-NSM
    870,714 shares@ £0.024716.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20170403112608_13181191_20200330131457597_1056-0
  • ▲
    Chief Operating Officer, Surgical Innovations Group plcExecutivesSurgical Innovations Group plc
    21,533 GBP0FCA-NSM
    605,714 shares@ £0.035616.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20170403112608_13181191_20200330131457597_1056-1
    Canonical exit: 29 Jun 2017 (T+90)

6 of 6 declarations